TELMA MCT 50/12.5 (Chlorthalidone (12.5mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg))

Telma-MCT 50/12.5 Tablet ER is a therapeutic combination indicated for managing high blood pressure (hypertension). Its mechanism involves relaxing blood vessels, which enhances the heart’s efficiency in circulating blood throughout the body. Additionally, this medication aids in the removal of excess water and certain electrolytes. It can be administered with or without meals, although taking it consistently at the same time daily is recommended to maximize its effectiveness. Due to its diuretic properties, it is advisable to take this medication during daytime hours or at least four hours before bedtime to minimize the likelihood of nocturnal urination. The exact dosage and frequency of use will be determined by your healthcare provider based on your specific condition. It is crucial to adhere to the prescribed regimen throughout the treatment duration. Some common side effects may include nausea, diarrhea, digestive disturbances, headaches, and dizziness. It is also recommended to regularly monitor kidney function and electrolyte levels during therapy. For optimal results, this medication should be coupled with lifestyle modifications such as a balanced diet, regular physical activity, and smoking cessation. Additionally, maintaining adequate hydration is important to combat potential dryness of the mouth and excessive thirst. Prior to initiation, it is important to inform your healthcare provider if you are pregnant, have a history of circulatory issues, or have existing liver or kidney conditions. Disclosing all concurrent medications is also essential, as interactions may alter the effectiveness or safety of this treatment.